DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slipped 1.67% to $794.19 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.25% to 7,711.76 and Dow Jones Industrial Average falling 0.02% to 53,559.99.
This was the stock's third consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed 6.23% below its 52-week high of $847.00, which the company reached on August 21st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ fell 1.05% to $432.42, Moderna Inc. (MRNA) fell 3.35% to $137.99, and Gilead Sciences Inc. (GILD) fell 2.14% to $145.68.
Trading volume (487,119) remained 367,151 below its 50-day average volume of 854,270.
Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.